Spondyloarthritis: new insights into clinical aspects, translational immunology and therapeutics
- 1 September 2018
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Rheumatology
- Vol. 30 (5) , 526-532
Abstract
Purpose of review: The spondyloarthopathies (SpA), which encompass related diseases that were originally viewed as autoimmune, are now known to have a strong innate immune or autoinflammatory initiation phase characterized by disease localization to tissue-specific sites based on the nuances and microanatomy and immunology of those sites. This review covers recent translational advances in the field of SpA. Recent findings: Imaging studies in SpA continue to add support for the pivotal role of enthesitis in disease initiation and expression. Although in its infancy, there is growing evidence for microbiotal intestinal dysbiosis in ankylosing spondylitis and psoriatic arthritis. The role of cytokines beyond tumour necrosis factor (TNF) continues to grow with support for the interleukin (IL)-23/17 axis being key to disease and emergent evidence for the importance of the IL-36 pathway. The treatment of inflammatory bowel disease (IBD) with vedolizumab an α4β7-integrin blocker has been associated with arthritis flares and small molecules with Janus kinase inhibition appear to be as effective as the anti-TNFs. The disparate response of different domains in SpA points towards immunological heterogeneity even within what was considered a homogeneous disease. Summary: The clinical aspects and translational immunology and therapeutics of SpA continue to evolve and indicate the complexity of diagnosis and treatment of these conditions.Keywords
This publication has 75 references indexed in Scilit:
- Synovial cytokine expression in psoriatic arthritis and associations with lymphoid neogenesis and clinical featuresArthritis Research & Therapy, 2012
- Diagnosis and classification in spondyloarthritis: identifying a chameleonNature Reviews Rheumatology, 2012
- IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonistProceedings of the National Academy of Sciences, 2012
- Mutations in IL36RN/IL1F5 Are Associated with the Severe Episodic Inflammatory Skin Disease Known as Generalized Pustular PsoriasisThe American Journal of Human Genetics, 2011
- Analysis of IL-17+cells in facet joints of patients with spondyloarthritis suggests that the innate immune pathway might be of greater relevance than the Th17-mediated adaptive immune responseArthritis Research & Therapy, 2011
- Association of STAT3 and TNFRSF1A with ankylosing spondylitis in Han ChineseAnnals of the Rheumatic Diseases, 2011
- Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitisClinical Rheumatology, 2010
- Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility lociNature Genetics, 2010
- Association of IL‐1 gene complex members with ankylosing spondylitis in Chinese Han populationInternational Journal of Immunogenetics, 2009
- Joint Extraintestinal Manifestations in Ulcerative ColitisDigestive Diseases, 2009